Palisade Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-120,779
Closed -$12.7M 521
2014
Q2
$12.7M Sell
120,779
-15,932
-12% -$1.67M 0.31% 122
2014
Q1
$11.3M Buy
+136,711
New +$11.3M 0.28% 141